ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

NIH Backs Down Agrees Nurses May Be Hired Into Commissioned Corps

June 13, 1986

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996

NCI Director Defends Goal to Eliminate Suffering, Death From Cancer by 2015

June 13, 2003